21 episodes
IndieBio -Designing Science IndieBio
-
- Business
-
-
4.8 • 14 Ratings
-
"Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.
IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology. We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 94 companies have graduated from the program, with a combined current valuation of over $700M.
IndieBio is a member of SOSV a $550M global fund focused on lasting impact.
Follow on www.twitter.com/indbio
https://m.facebook.com/indiebio/?ref=m_notif¬if_t=feedback_reaction_generic
-
Arvind Gupta & Jim Collins
Jim Collins, bioengineer, and Termeer Professor of Medical Engineering & Science and Professor of Biological Engineering at MIT. on "Designing Science" podcast with Arvind Gupta, Founder and Venture Advisor at IndieBio, Partner at Mayfield
IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.
We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $2B.
IndieBio is a member of SOSV a $700M global fund focused on lasting impact. -
Arvind Gupta & Alex Lorestani
Alex Lorestani, CEO & Co-founder of Geltor featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.
IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.
We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $2B.
IndieBio is a member of SOSV a $700M global fund focused on lasting impact.
Follow on www.twitter.com/indbio -
Arvind Gupta & Calvin Nguyen
Calvin Nguyen, co-founder of BrainMind featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.
IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.
We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $2B.
IndieBio is a member of SOSV a $700M global fund focused on lasting impact.
Follow on www.twitter.com/indbio -
Arvind Gupta & Jessica Briggs
Jessica Briggs, UCSF Clinical Research Fellow in Infectious Diseases featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.
IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.
We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $2B.
IndieBio is a member of SOSV a $700M global fund focused on lasting impact.
Follow on www.twitter.com/indbio -
Arvind Gupta & Vladimir Bulovic
Vladimir Bulovic, Director of MIT.nano featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.
IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.
We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $2B.
IndieBio is a member of SOSV a $700M global fund focused on lasting impact.
Follow on www.twitter.com/indbio -
Arvind Gupta with Emily Leproust
Emily Leproust, CEO of Twist Biosciences featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.
IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.
We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $2B.
IndieBio is a member of SOSV a $700M global fund focused on lasting impact.
Follow on www.twitter.com/indbio
Customer Reviews
So much gooey sciencey goodness
You know why you’re here. Learn about biology and how it will shape the future from the perspective of scientists, investors, and entrepreneurs
Awesome Podcast
I have been waiting for this exact podcast. Looking forward to some in-depth discussions on biotech that I can listen to while doing science in my own lab!